Brambles to exit India with $85m CHEP sale—find out why it’s a game-changer
Brambles Limited, a leader in supply-chain logistics and pooling solutions, has entered into an agreement to sell its CHEP India business to LEAP India Private ... Read More
Geotechnical work kicks off for NSW’s high-speed rail link to Sydney
Geotechnical work has commenced for the much-anticipated high-speed rail link between Sydney and Newcastle, marking the beginning of an ambitious infrastructure project set to reshape ... Read More
Arthur J. Gallagher & Co. expands reach with acquisitions of Filos Agency, Via Financial Group, and Redington Ltd
Arthur J. Gallagher & Co. has solidified its position in the insurance and financial services markets by announcing three strategic acquisitions: New York-based Filos Agency, ... Read More
Arthur J. Gallagher expands with strategic acquisitions in Australia and UK
In a bid to strengthen its financial advisory footprint, Arthur J. Gallagher & Co. announced two key acquisitions, targeting firms with specialized financial expertise in ... Read More
WiseTech CEO Richard White steps down amid scandal, shares rally
WiseTech Global, Australia’s premier logistics software giant, has witnessed a surprising resurgence in its share price following the announcement that its embattled CEO and founder, ... Read More
TZ Limited announces acquisition of Keyvision to boost proptech capabilities
TZ Limited, a leader in smart locker solutions, has announced a strategic acquisition aimed at expanding its proptech capabilities. The company entered a Heads of ... Read More
Echo IQ’s EchoSolv AS gains FDA approval—AI-powered solution to tackle underdiagnosed Aortic Stenosis
Sydney-based AI medical technology company, Echo IQ Limited, has achieved a significant breakthrough with the US Food and Drug Administration (FDA) clearance for its EchoSolv ... Read More
Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial
Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute Myelogenous Leukemia (AML) has exhibited a complete ... Read More
Immutep completes patient enrolment for Phase II trial of eftilagimod alpha in metastatic breast cancer
Immutep Limited, a clinical-stage biotechnology company specializing in advanced LAG-3 immunotherapies, has announced the completion of patient enrolment for its Phase II AIPAC-003 clinical trial. ... Read More
Cokal Limited expands coal transport infrastructure to accelerate BBM production ramp-up
In a strategic effort to enhance the ramp-up of BBM metallurgical coal production, Cokal Limited has significantly augmented its coal transport infrastructure by collaborating with ... Read More